https://www.premera.com/medicalpolicies/5.01.589.pdf#search=policy
PHARMACY POLICY - 5.01.589 BRAF and MEK Inhibitors Effective Date: May 1, 2025 Last ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/5.01.590.pdf#search=policy
PHARMACY POLICY - 5.01.590 Bruton's Kinase Inhibitors Effective Date: Mar. 1, 2025 Last ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/5.01.595.pdf#search=policy
PHARMACY/MEDICAL POLICY - 5.01.595 Injectable Clostridial Collagenase for Fibroproliferative Disorders BCBSA Ref. Policy: 5.01.19 Effective Date: Apr. 1, 2025 Last Revised: Mar. ...
https://www.premera.com/medicalpolicies/5.01.610.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.610 Pharmacologic Treatment in Assisted Reproduction ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/5.01.617.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.617 Folate Antimetabolites Effective Date: Mar. 1, 2025 ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/5.01.623.pdf#search=policy
PHARMACY POLICY - 5.01.623 Topical Drugs for Actinic Keratosis and Other Dermatologic ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/7.01.07.pdf#search=policy
MEDICAL POLICY - 7.01.07 Electrical Bone Growth Stimulation of the Appendicular Skeleton BCBSA Ref. Policy: 7.01.07 Effective Date: July 1, 2024 Last Revised: June 10, 2024 ...
https://www.premera.com/medicalpolicies/7.01.159.pdf#search=policy
MEDICAL POLICY - 7.01.159 Sphenopalatine Ganglion Block for Headache BCBSA Ref. Policy: 7.01.159 Effective Date: Feb. 1, 2025 Last Revised: Jan. 13, 2025 Replaces: N/A RELATED ...
https://www.premera.com/medicalpolicies/7.01.583.pdf#search=policy
MEDICAL POLICY - 7.01.583 Amniotic Membrane and Amniotic Fluid BCBSA Ref. Policy: 7.01.149 Effective Date: Jul. 1, 2025 Last Revised: Jun. 10, 2025 Replaces: N/A RELATED MEDICAL ...
https://www.premera.com/medicalpolicies/7.01.567.pdf#search=policy
MEDICAL POLICY - 7.01.567 Surgical Treatments for Lymphedema and Lipedema BCBSA Ref. Policy: 7.01.162, 7.01.169, 7.01.173 Effective Date: March 5, 2025 Last Revised: Nov. 12, 2024 ...
https://www.premera.com/medicalpolicies/8.01.42.pdf#search=policy
MEDICAL POLICY - 8.01.42 Hematopoietic Cell Transplantation for Primary Amyloidosis BCBSA Ref. Policy: 8.01.42 Effective Date: Apr. 1, 2025 Last Revised: Mar. 10, 2025 Replaces: ...
https://www.premera.com/medicalpolicies/8.01.62.pdf#search=policy
MEDICAL POLICY - 8.01.62 Electronic Brachytherapy for Nonmelanoma Skin Cancer BCBSA Ref. Policy: 8.01.62 Effective Date: Oct. 1, 2024 Last Revised: Sept. 9, 2024 Replaces: N/A ...
https://www.premera.com/medicalpolicies/8.01.63.pdf#search=policy
MEDICAL POLICY - 8.01.63 Chimeric Antigen Receptor Therapy for Leukemia and Lymphoma BCBSA Ref. Policy: 8.01.63 Effective Date: Mar. 1, 2025 Last Revised: Jul. 1, 2025 Replaces: ...
https://www.premera.com/medicalpolicies/5.01.587_2025-10-03.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.587 Hereditary Angioedema Effective Date: Oct. 3, 2025* Last Revised: Jun. 10, 2025 Replaces: N/A *This policy has been revised. Click here to view the ...
https://www.premera.com/medicalpolicies/5.01.591_2025-10-03.pdf#search=policy
MEDICAL POLICY - 5.01.591 Immune Checkpoint Inhibitors Effective Date: Oct. 3, 2025* Last Revised: Jun. 10, 2025 Replaces: N/A *This policy has been revised. Click here to view the ...
https://www.premera.com/medicalpolicies/10.01.520.pdf#search=policy
BENEFIT COVERAGE GUIDELINE - 10.01.520 Review for Coverage in the Absence of a Medical Policy, Pharmacy Policy, or Utilization Management Guideline Effective Date: Aug. 1, 2024 ...
https://www.premera.com/medicalpolicies/5.01.555.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.555 Pharmacologic Treatment of Interstitial Lung Disease ... below to be directed to that section. POLICY CRITERIA | CODING | RELATED INFORMATION ...
https://www.premera.com/medicalpolicies/5.01.568.pdf#search=policy
PHARMACY POLICY - 5.01.568 Venclexta (venetoclax) BCL-2 Inhibitor Effective Date: Apr. 1, ... POLICY CRITERIA | CODING | RELATED INFORMATION EVIDENCE REVIEW | REFERENCES | HISTORY ∞ ...
https://www.premera.com/medicalpolicies/5.01.581.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.581 Pharmacologic Treatment of Hemophilia BCBSA Ref. Policy: 8.01.65 Effective Date: May 1, 2025 Last Revised: Jul. 1, 2025 Replaces: N/A RELATED ...
https://www.premera.com/medicalpolicies/5.01.585.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.585 Pharmacologic Treatment of Phenylketonuria Effective ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...